Remote Monitoring Strategy to Enable Same-Day Discharge After Transcatheter Aortic Valve Implantation Compared to Standard Care
Led by Imperial College London · Updated on 2026-03-03
216
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a remote monitoring approach for patients who have undergone Transcatheter Aortic Valve Implantation TAVI, focusing on reducing hospital stays and readmissions after the procedure. This trial aims to address common heart rhythm problems that can occur post-TAVI, such as heart block, which sometimes requires pacemaker insertion. The study seeks to improve patient care by using technology to monitor heart function and detect issues early, potentially allowing for same-day discharge.
Participants will be randomly assigned to either a remote monitoring group or a standard care group. Those in the remote monitoring group will receive four devices, including a continuous 7-lead ECG patch worn for 72 hours after discharge, and will perform daily 12-lead ECGs along with vital sign recordings for seven days. This group will be supported by a clinical decision algorithm to guide care. The control group will follow the best current standard of care without additional monitoring devices.
Throughout the study, participants will be closely monitored for clinical data including ECG changes, vital signs, and adverse events. Researchers will assess outcomes such as hospital length of stay within 30 days, need for pacemaker implantation, emergency visits, hospital admissions, and mortality rates. Anxiety levels will also be measured. The trial includes daily remote consultations when needed, with a follow-up period extending up to three months for some outcomes, aiming to optimize post-TAVI patient management and safety.
CONDITIONS
Brief Title
Remote Cardiovascular Monitoring in Post-TAVI Patients
Research Team
B
Badr Al Harbi, BScEMS, MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Post-TAVI patients without serious complications hindering same-day discharge, including controlled vascular issues, clear neurological status, and no significant pericardial effusion.
Elective non-emergent admissions and nonelective cases meeting discharge criteria.
Comfortable ambulation after the procedure.
Patient or caregiver must have access to a smart device.
Ability to provide informed consent (alert and oriented).
Adequate social support.
You will not qualify if you...
Hemodynamically unstable post-TAVI condition, cardiac arrest, stroke, acute kidney injury, or major bleeding requiring transfusion.
Patients with a permanent implanted pacing device.
Procedural failure in device delivery.
Major vascular access complications requiring hospital stay.
Inability to engage with the technology.
Significant communication barriers.
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Up to 30 days after the procedure
Participants undergo transcatheter aortic valve implantation (TAVI) followed by either a remote patient monitoring strategy or standard medical therapy to manage post-procedural care.
Continuous remote monitoring for 72 hours post-discharge and daily ECG and vital sign recordings up to 7 days; remote consultations as needed
Follow-up
Duration - Up to 3 months after the procedure
Participants are monitored for hospital readmissions, emergency room visits, and adverse cardiovascular events up to 3 months after the procedure.
Follow-up assessments at discharge, 30 days, and 3 months
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Evaluation of a 10-Minute Cardiovascular Magnetic Resonance Protocol for Diagnosing Cardiac Diseases Including Coronary Artery Disease and Cardiomyopathies
Prospective Study to Collect CT Imaging and Echocardiography Data for Predicting Outcomes After Transcatheter Aortic Valve Implantation
Evaluating AI-Assisted Digital Management to Improve Medication Safety and Reduce Healthcare Burden in Advanced Solid Tumors A Controlled Real-World Study
Evaluating Safety and Effectiveness of the Edwards SAPIEN X4 Balloon-Expandable Transcatheter Heart Valve for Treating Failing Aortic Bioprosthetic Valves
Study of Angiotensin Receptor Blockers to Slow Progression of Mild to Moderate Aortic Stenosis and Improve Heart Function
Heparin Reversal With Protamine Sulfate to Reduce Complications After Transcatheter Aortic Valve Replacement for Aortic Stenosis
Comparing Transcatheter and Surgical Aortic Valve Replacement in Patients Over 50 with Severe Aortic Valve Narrowing and Bicuspid Valve
Evaluating the EmStop Embolic Protection System Compared to the Sentinel Device During Self-Expanding Transcatheter Aortic Valve Replacement for Aortic Valve Stenosis
CardioHeartConnect Mobile Cardiac Rehabilitation Using Peloton Fitness Modules
Compared to Educational Materials for Patients Recovering from Transcatheter Aortic Valve Replacement
Evaluating Remote Patient Monitoring Integration in Outpatient Diabetes Care
A Real-World Study of Over 12,000 People With Diabetes at Steno Diabetes Center Copenhagen
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Catherine M Otto, Rick A Nishimura, Robert O Bonow...
Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study.
Joanna L d'Arcy, Sean Coffey, Margaret A Loudon...